Search Results
Results found for "Jurgen Wess"
- 📅 Dr. GPCR Summit 2022 is less than a month away!
GPCR Summit 2022 is less than a month away!
- Carola Weiss joins InterAx Biotech AG as VP Business Development
February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical Carola Weiss’ professional career brings deep expertise in business development, marketing & sales, licensing
- 📰 GPCR Weekly News, June 3 to June 9, 2024
Jürgen Wess and Liu Liu for their study on A novel function of the M2 muscarinic receptor Drs.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Now, there’s less competition and more opportunity.”
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
In fact, it all began with a phone call (from Bruce Merrifield, no less) encouraging Sakmar to work on
- Nanobodies: New Dimensions in GPCR Signaling Research
C., Wess, J., & Kobilka, B. K. (2013).
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Yet, far less time is spent scrutinizing the structural logic and origin of the molecules we screen Less than ~15% of higher plant species, <5% of bacterial and fungal species, and only a fraction of marine
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility
- G protein-coupled receptor signaling: transducers and effectors
We will first summarize their prominent roles in GPCR pharmacology before transitioning into less well-explored
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
In a constant effort to develop drugs with less side effects, and tools to explore the ORs nature and
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
through the mu-opioid receptor, blunts the brainstem’s inspiratory drive so that each breath draws in less two drugs, there was a potentiation of fentanyl’s effect on tidal volume—mice were bringing in even less
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
Serafini’s work on RGS proteins suggests a quieter, but no less powerful, frontier in the fight against
- The complicated lives of GPCRs in cardiac fibroblasts
Here, we will focus on the relatively less well-studied effects of GPCRs in cardiac fibroblasts, focusing
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
In less than a decade, nanobodies, or recombinant single-domain antibody fragments from camelids, have
- Newly launched antibody libraries put hard-to-drug targets within reach
November 2021 "Target class-specific libraries mean you need to screen less to identify high-quality
- Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
In contrast, less is known about the expression and function of the GLP-1R in human T cells.
- From GPCR Data Chaos to Decisive Action
They stall because the data becomes a mess.
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
For proteins with low sequence similarity to available templates, homology models tend to be less accurate
- Reflections on My PhD Journey: Lessons Learned
ensures that you remain on top of your findings but also makes the thesis-writing process significantly less
- Canonical chemokine receptors as scavenging “decoys”
Although less characterized, canonical CKRs have also been shown to not only directly regulate migration
- From Pipettes to Platforms: The Evolution of GPCR Research
Today, success depends less on manual precision and more on experimental design, data interpretation,
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
dynamics of GPCR activation has always been a challenge because G protein activation in cells occurs in less
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
Academic success is less about prestige than about impact.
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
Understanding the evolutionary conservation of these residues can lead to the development of drugs that are less
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Extending Schild to Partial Agonists Partial agonists complicate things—they activate receptors but less
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
It’s less bureaucratic than most outsiders think.
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
It’s built for the GPCR community—by people who live the science—so you spend less time sifting and more
- 📰 GPCR Weekly News, June 5 to 11, 2023
Reviews, GPCRs, and more Diversification processes of teleost intron-less opsin genes.
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
These agonists exhibit less interaction with ECL3, resulting in an open conformation of the TM6-ECL3-















